Joshua Rosenthal is a Senior Scientist at the Marine Biological Laboratory (MBL) in Woods Hole, Massachusetts. He received his Ph.D. in Biology from Stanford University and completed his postdoctoral training in biophysics and physiology at UCLA. Before coming to the Marine Biological Laboratory, he rose from Assistant to Full Professor at the University of Puerto Rico’s Medical Sciences Campus. Dr. Rosenthal’s research focuses on the process of RNA editing from a variety of angles. His group has shown that mRNA recoding is unusually active in cephalopods. They are interested in how cephalopod RNA editing can respond to environmental cues and how the underlying machinery for RNA editing in this taxon is able to drive such extensive recoding. The Rosenthal lab also pioneered systems to use RNA editing as a therapeutic in order to correct genetic mutations and engineer protein function. Dr. Rosenthal is a founder of Korro Bio, a biotech in Cambridge MA that is developing RNA editing platforms to treat human disease.